Morpholino

MO4-vcp

ID
ZDB-MRPHLNO-181217-1
Name
MO4-vcp
Previous Names
None
Target
Sequence
5' - AAGCCATATTGCTTCTCCCGCAAAA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Translation-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO4-vcp
Expressed Gene Anatomy Figures
vcp Fig. 1 with image from Kustermann et al., 2018
Phenotype
Phenotype resulting from MO4-vcp
Phenotype Fish Figures
autophagy decreased occurrence, abnormal WT + MO4-vcp Fig. 3 with image from Kustermann et al., 2018
blood circulation decreased magnitude, abnormal WT + MO4-vcp Fig. 1 with image from Kustermann et al., 2018
heart edematous, abnormal WT + MO4-vcp Fig. 1 with image from Kustermann et al., 2018
heart contraction decreased frequency, abnormal WT + MO4-vcp Fig. 1 with image from Kustermann et al., 2018
heart contraction decreased magnitude, abnormal WT + MO4-vcp Fig. 1 with image from Kustermann et al., 2018
involuntary skeletal muscle contraction decreased occurrence, abnormal WT + MO4-vcp Fig. 1 with image from Kustermann et al., 2018
myotome skeletal muscle malformed, abnormal WT + MO4-vcp Fig. 1 with imageFig. 2 with image from Kustermann et al., 2018
myotome skeletal muscle cell has extra parts of type skeletal muscle cell vesicle, abnormal WT + MO4-vcp Fig. 2 with image from Kustermann et al., 2018
proteasome-mediated ubiquitin-dependent protein catabolic process decreased occurrence, abnormal WT + MO4-vcp Fig. 3 with image from Kustermann et al., 2018
skeletal muscle mitochondrion malformed, abnormal WT + MO4-vcp Fig. 2 with image from Kustermann et al., 2018
skeletal muscle skeletal muscle myofibril disorganized, abnormal WT + MO4-vcp Fig. 2 with image from Kustermann et al., 2018
skeletal muscle skeletal myofibril assembly decreased process quality, abnormal WT + MO4-vcp Fig. 2 with image from Kustermann et al., 2018
skeletal muscle cell Z disc malformed, abnormal WT + MO4-vcp Fig. 2 with image from Kustermann et al., 2018
thigmotaxis decreased occurrence, abnormal WT + MO4-vcp Fig. 1 with image from Kustermann et al., 2018
whole organism vcp expression decreased amount, abnormal WT + MO4-vcp Fig. 1 with image from Kustermann et al., 2018
whole organism ab1-map1lc3 labeling increased amount, abnormal WT + MO4-vcp Fig. 3 with image from Kustermann et al., 2018
whole organism Ab7-sqstm1 labeling increased amount, abnormal WT + MO4-vcp Fig. 3 with image from Kustermann et al., 2018
whole organism Ab4-ub labeling increased amount, abnormal WT + MO4-vcp Fig. 3 with image from Kustermann et al., 2018
Phenotype of all Fish created by or utilizing MO4-vcp
Phenotype Fish Conditions Figures
involuntary skeletal muscle contraction decreased occurrence, abnormal WT + MO4-vcp standard conditions Fig. 1 with image from Kustermann et al., 2018
whole organism Ab4-ub labeling increased amount, abnormal WT + MO4-vcp control Fig. 3 with image from Kustermann et al., 2018
heart edematous, abnormal WT + MO4-vcp standard conditions Fig. 1 with image from Kustermann et al., 2018
whole organism Ab4-ub labeling increased amount, abnormal WT + MO4-vcp chemical treatment by environment: N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal Fig. 3 with image from Kustermann et al., 2018
autophagy decreased occurrence, abnormal WT + MO4-vcp chemical treatment by environment: ammonium chloride Fig. 3 with image from Kustermann et al., 2018
heart contraction decreased magnitude, abnormal WT + MO4-vcp standard conditions Fig. 1 with image from Kustermann et al., 2018
skeletal muscle skeletal myofibril assembly decreased process quality, abnormal WT + MO4-vcp standard conditions Fig. 2 with image from Kustermann et al., 2018
skeletal muscle mitochondrion malformed, abnormal WT + MO4-vcp standard conditions Fig. 2 with image from Kustermann et al., 2018
whole organism Ab7-sqstm1 labeling increased amount, abnormal WT + MO4-vcp control Fig. 3 with image from Kustermann et al., 2018
proteasome-mediated ubiquitin-dependent protein catabolic process decreased occurrence, abnormal WT + MO4-vcp control Fig. 3 with image from Kustermann et al., 2018
blood circulation decreased magnitude, abnormal WT + MO4-vcp standard conditions Fig. 1 with image from Kustermann et al., 2018
autophagy decreased occurrence, abnormal WT + MO4-vcp control Fig. 3 with image from Kustermann et al., 2018
skeletal muscle skeletal muscle myofibril disorganized, abnormal WT + MO4-vcp standard conditions Fig. 2 with image from Kustermann et al., 2018
whole organism vcp expression decreased amount, abnormal WT + MO4-vcp standard conditions Fig. 1 with image from Kustermann et al., 2018
myotome skeletal muscle malformed, abnormal WT + MO4-vcp standard conditions Fig. 1 with imageFig. 2 with image from Kustermann et al., 2018
whole organism ab1-map1lc3 labeling increased amount, abnormal WT + MO4-vcp control Fig. 3 with image from Kustermann et al., 2018
thigmotaxis decreased occurrence, abnormal WT + MO4-vcp standard conditions Fig. 1 with image from Kustermann et al., 2018
myotome skeletal muscle cell has extra parts of type skeletal muscle cell vesicle, abnormal WT + MO4-vcp standard conditions Fig. 2 with image from Kustermann et al., 2018
whole organism ab1-map1lc3 labeling increased amount, abnormal WT + MO4-vcp chemical treatment by environment: ammonium chloride Fig. 3 with image from Kustermann et al., 2018
proteasome-mediated ubiquitin-dependent protein catabolic process decreased occurrence, abnormal WT + MO4-vcp chemical treatment by environment: N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal Fig. 3 with image from Kustermann et al., 2018
heart contraction decreased frequency, abnormal WT + MO4-vcp standard conditions Fig. 1 with image from Kustermann et al., 2018
skeletal muscle cell Z disc malformed, abnormal WT + MO4-vcp standard conditions Fig. 2 with image from Kustermann et al., 2018
Citations